AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
CGC   19.90 (-0.55%)
BABA   201.18 (-0.27%)
MU   49.45 (+7.97%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
F   6.03 (+3.25%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
NFLX   419.89 (+1.23%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NYSEAMERICAN:NAVBNavidea Biopharmaceuticals Earnings Date, Estimates & History

$2.44
-0.06 (-2.40 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.27
Now: $2.44
$2.50
50-Day Range N/A
52-Week Range
$0.49
Now: $2.44
$3.50
Volume1.37 million shs
Average Volume1.04 million shs
Market Capitalization$52.81 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Earnings

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Earnings Information

Navidea Biopharmaceuticals last posted its quarterly earnings data on March 11th, 2020. The biopharmaceutical company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.03. The business had revenue of $0.12 million for the quarter, compared to analyst estimates of $0.30 million. Navidea Biopharmaceuticals has generated $0.00 earnings per share over the last year. Navidea Biopharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2020 based off prior year's report dates.

Navidea Biopharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Navidea Biopharmaceuticals (NYSEAMERICAN NAVB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/13/2020
(Estimated)
       
3/11/2020Q4 2019($0.12)($0.15)($0.15)$0.30 million$0.12 millionTranscript
11/7/2019Q3($0.17)($0.17)($0.17)$0.24 millionTranscript
8/8/2019Q2 2019($0.15)($0.24)($0.24)$0.26 millionTranscript
5/8/20193/31/2019($0.24)($0.24)$0.14 millionTranscript
3/7/201912/31/2018($0.02)($0.02)$0.12 millionTranscript
11/7/20189/30/2018($0.02)($0.02)$0.23 millionN/A
8/8/2018Q2 2018($0.02)($0.02)$0.54 millionN/A
5/8/2018Q1 2018($0.04)($0.04)$0.28 millionN/A
3/8/2018Q4 2017($0.03)($0.03)$0.40 millionN/A
11/7/2017Q3 2017($0.01)($0.01)$0.22 millionN/A
8/8/2017Q2 2017($0.02)($0.01)$0.61 millionListen
5/9/2017Q1 2017($0.01)($0.54)$0.58 millionN/A
3/29/2017Q4 2016($0.02)($0.02)$3.36 millionN/A
8/4/2016Q216($0.03)($0.04)($0.04)$5.24 million$5.40 millionN/A
5/17/2016Q1($0.03)($0.02)($0.02)$4.63 million$4.70 millionListen
3/23/2016Q415($0.04)($0.02)($0.02)$3.70 million$4.00 millionListen
11/4/2015Q315($0.04)($0.05)($0.05)$2.40 million$3.98 millionListen
7/30/2015Q2 2015($0.60)$2.18 million$2.90 millionListen
5/12/2015Q115($0.03)($0.05)($0.05)$3.30 million$2.10 millionListen
3/5/2015($0.04)($0.05)$1.95 million$2.20 millionN/A
3/5/2015($0.04)($0.05)$1.95 million$2.20 millionN/A
3/5/2015Q414($0.05)($0.05)($0.05)$2.10 million$2.20 millionListen
11/6/2014Q314($0.06)($0.05)($0.05)$1.54 million$2.30 millionListen
8/6/2014Q214($0.07)($0.07)($0.07)$1.05 million$1.05 millionListen
5/7/2014Q114($0.10)($0.06)($0.04)$0.90 million$0.75 millionListen
3/6/2014Q4 2013($0.10)($0.10)$0.74 million$0.54 millionListen
11/6/2013Q3 2013($0.09)($0.09)$0.97 million$0.40 millionListen
8/7/2013Q2 2013($0.06)($0.08)($0.07)$0.55 million$0.20 millionTranscript
5/8/2013Q1 2013($0.06)($0.06)($0.06)$0.02 millionTranscript
3/6/2013Q4 2012($0.08)($0.08)Transcript
11/8/2012Q312$0.21($0.09)Transcript
8/6/2012Q2 2012($0.06)($0.06)($0.06)N/A
5/2/2012Q1 2012($0.07)($0.07)($0.06)N/A
2/29/2012Q4 2011($0.05)($0.08)($0.08)N/A
10/26/2011Q3 2011($0.03)($0.07)($0.35)N/A
7/27/2011Q2 2011($0.02)($0.02)($0.02)N/A
5/9/2011Q1 2011($0.02)($0.05)($0.05)N/A
3/7/2011Q4 2010($0.03)($0.03)($0.03)N/A
11/10/2010Q3 2010($0.01)($0.03)($0.03)N/A
8/9/2010Q2 2010($0.02)($0.02)$0.60N/A
4/28/2010Q1 2010($0.01)($0.03)($0.03)N/A
11/2/2009Q3 2009($0.31)($0.10)$0.14N/A
8/11/2009Q2 2009($0.02)($0.02)$0.17N/A
5/6/2009Q1 2009$0.01$0.01N/A
3/10/2009Q4 2008($0.03)($0.02)($0.02)N/A
11/5/2008Q3 2008($0.02)($0.03)($0.03)N/A
8/4/2008Q2 2008($0.03)($0.02)($0.02)N/A
5/1/2008Q1 2008($0.01)($0.02)($0.02)N/A
3/19/2008Q4 2007($0.01)($0.02)($0.01)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.